GlassScriptPhysician profile
Alaine E Gada
NPI 1871794339
$1,485.84
in general payments reported to CMS, 2019-2025
18 companies · $1,118 in 2025
The $1,118 reported for 2025 was more than what 80% of Nephrology (Internal Medicine) providers received nationally (typical 2025 total: $311).
See the full distribution for Nephrology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $22.07 · 2023: $182 · 2024: $164 · 2025: $1,118.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,461 · Education: $3.08.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,460.69 |
| Education | $3.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vifor Pharma, INC. | $255.65 | 2023-2025 | Veltassa |
| Fresenius USA Marketing, INC. | $152.25 | 2025 | Velphoro |
| Vantive US Healthcare LLC | $145.17 | 2025 | Renal - Acute |
| Amgen INC. | $125.91 | 2024-2025 | Tavneos, Krystexxa |
| Otsuka America Pharmaceutical, INC. | $120.52 | 2024-2025 | Jynarque, Voyxact |
| Calliditas Therapeutics US INC. | $117.28 | 2025 | Tarpeyo |
| Travere Therapeutics, INC. | $103.20 | 2023-2025 | |
| Ardelyx, INC. | $85.59 | 2024-2025 | Ibsrela |
| Apellis Pharmaceuticals, INC. | $80.79 | 2025 | Empaveli |
| Scpharmaceuticals INC. | $75.28 | 2025 | |
| Akebia Therapeutics INC | $47.29 | 2025 | Vafseo |
| Astrazeneca Pharmaceuticals LP | $37.53 | 2025 | Farxiga, Lokelma |
| Novartis Pharmaceuticals Corporation | $28.24 | 2025 | |
| Recor Medical INC | $24.86 | 2025 | Paradise Ultrasound Renal Denervation System |
| Opko Pharmaceuticals, LLC | $23.48 | 2025 | Rayaldee |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $22.88 | 2023 | Acthar |
| Aurinia Pharma U.S., INC. | $22.07 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.85 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alaine Gada listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.